Abdominal Pain clinical trials

Explore recruiting abdominal pain clinical trials.

Recruiting abdominal pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Abdominal Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, 12-month Phase 3 Study to Evaluate the Effect of Venglustat on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age with Fabry Disease who are treatment-naïve or Untreated for at Least 6 Months

Norway, Poland, France, Romania, Italy, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase-II randomized clinical trial to evaluate the effect of Loratadine associated with Rapamune on Lymphagioleiomyomatosis (LAM).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Pilot / Phase 2 Clinical Trial of GSL-01-001 Administered Orally for 12 Weeks Preceded by a 2 Week Screening Period in Patients Presenting with Symptoms Associated with Irritable Bowel Syndrome with code GSL-01-001

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A double-blind, randomized, placebo-controlled, multicenter trial evaluating the efficacy and safety of Saccharomyces boulardii CNCM I-745 in adult patients with non-constipated Irritable Bowel Syndrome.

Portugal, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Abdominal Pain trials by city

Abdominal Pain in Toronto Abdominal Pain in Vancouver Abdominal Pain in Montreal Abdominal Pain in Calgary Abdominal Pain in Edmonton Abdominal Pain in Ottawa Abdominal Pain in Winnipeg Abdominal Pain in Quebec City Abdominal Pain in Hamilton Abdominal Pain in Kitchener Abdominal Pain in London Abdominal Pain in Halifax Abdominal Pain in New York Abdominal Pain in Los Angeles Abdominal Pain in Chicago Abdominal Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease